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  Echinacea (E.) purpurea herb is commonly known as the 
purple coneflower, red sunflower and rudbeckia. In this 
paper, we report the curative efficacy of an Echinacea ex-
tract in γ-irradiated mice. E. purpurea was given to male 
mice that were divided into five groups (control, treated, 
irradiated, treated before irradiation & treated after irra-
diation) at a dose of 30 mg/kg body weight for 2 weeks be-
fore and after irradiation with 3 Gy of γ-rays. The results 
reflected the detrimental reduction effects of γ-rays on pe-
ripheral  blood  hemoglobin  and t h e  l e v e l s  o f  r e d  b l o o d  
cells, differential white blood cells, and bone marrow cells. 
The thiobarbituric acid-reactive substances (TBARs) lev-
e l ,  S u p e r o x i d e  d i s m u t a s e  ( S O D )  a n d  g l u t a t h i o n e  p e r o x -
idase (GSPx) activities and DNA fragmentation were also 
investigated. FT-Raman spectroscopy was used to explore 
the structural changes in liver tissues. Significant changes 
were observed in the microenvironment of the major con-
stituents, including tyrosine and protein secondary struc-
tures.  E.  purpurea  administration  significantly  amelio-
rated all estimated parameters. The radio-protection ef-
fectiveness was similar to the radio-recovery curativeness 
in comparison to the control group in most of the tested 
parameters.  The  radio-protection  efficiency  was  greater 
than  the  radio-recovery  in  hemoglobin  level  during  the 
first two weeks, in lymphoid cell count and TBARs level at 
the fourth week and in SOD activity during the first two 
weeks, as compared to the levels of these parameters in the 
control group.
Key words:  Echinacea purpurea,  γ-rays, immunostimulant, 
radio-protection, radio-recovery
Introduction 
  Antioxidants protect against radiation-induced oncogenic 
transformation in experimental systems [9]. Many natural 
and synthetic compounds have been investigated for their 
efficacy to protect against irradiation damage [35]. 
Previous studies developed radio-protective and radio-re-
covery agents to protect from the indirect effects of radia-
tion by eliminating free radicals produced in response to 
radiation [54] and immunostimulants to counteract im-
mune suppression [61]. Supplementary phytochemicals, 
including polyphynols, flavonoids, sulfhydryl com-
pounds, plant extracts and immunomodulators, are anti-
oxidants and radioprotective in experimental systems [55]. 
A potential treatment strategy for radiation exposure might 
be to strengthen the immune system [19]. 
  The recent use of numerous herbal products as dietary 
supplements places them in a unique category of food to 
drugs (nutraceuticals) that are used for their therapeutic 
value. The realistic distinction between foods, dietary sup-
plements, and drugs is often based on their future uses [10].
  Echinacea ( E.)  purpurea was used to treat dizziness, 
snake bites and as an anti-infective agent until the advent of 
modern antibiotics [27]. Its recent resurgence as a treat-
ment for recurrent genital herpes [57] and acute upper res-
piratory tract infections [46] has placed Echinacea among 
the most widely used herbs in the United States and 
Europe. In addition, Echinacea is also used as a pre-
operative herbal remedy [2], and it has anti-tumor [7] and 
anti-inflammatory [41] activities.
  E. purpurea contains large amounts of chicoric acid and 
caftaric acid, which are largely recognized in the inhibition 
of hyaluronidase which is secreted by streptococci and oth-
er bacteria to enable penetration into tissue, has been dem-
onstrated with Echinacea plant juice [31]. It also controls 
candidiasis infestation [22], enhances resistance to influ-
enza viruses [49] and vesicular stomatitis virus [6] and en-342    Amira M. K. Abouelella et al.
hances phagocytosis when administered orally to mice 
[12] and humans [26]. This phagocytic enhancement is at-
tributed to its isobutylamide content, which inhibits the 
pro-inflammatory metabolite production induced by lip-
oxygenase [22] and is responsible for the local anaesthetic 
effects applied to relieve oral pain, such as toothaches and 
sore throats [37]. 
  The  "immune  stimulation"  by  E. purpurea observed 
in-vitro and after parenteral administration has not been 
confirmed after oral intake in rats [52] and humans [47], 
and its preparations were immunologically inactive, even 
though they did show antioxidant and anti-inflammatory 
activities [42]. Other studies concerning the management 
of sinusitis in adults have demonstrated the efficacy of E. 
purpurea in the stimulation of the immune system, thereby 
reducing the incidence, duration and severity of respiratory 
infections [56]. The efficacy of E. purpurea has also been 
demonstrated in supportive treatment of urinary infections 
and for the external treatment of wounds and chronic ar-
thritis [8]. New investigations have also shown that macro-
phage stimulation and the induction of cytokines are major 
parts of the mode of action [5]. Additionally, root extracts 
of E. purpurea were found to contain anti-oxidant com-
pounds [39], to be capable of scavenging hydroxyl radicals 
and to suppress the oxidation of human low-density lip-
oprotein [21].
  Most of the E. purpurea-related studies did not involve a 
thorough structural exploration of tissue proteins, partic-
ularly at the molecular level. Therefore, we used near-in-
frared Fourier transform Raman spectroscopy to study the 
structural changes of major liver constituents in irradiated 
mice. 
    The preventive and therapeutic properties of the im-
munomodulator and immunonutrient  E. purpurea against 
radiation were reviewed by evaluating the changes in bone 
marrow and peripheral blood cell count and peripheral 
blood antioxidant activity.
Materials and Methods
Administration of E. purpurea 
  Standardized  dried  powder  extract  from  E. purpurea 
(Echinacin; Madaus AG, Germany) at a dose of 30 mg/kg 
body wt/day, was suspended in 1.0 ml of saline and gav-
aged to each animal for 2 weeks as previously described by 
Di Carlo [13]. The dried powder extract from E. purpurea 
includes caffeic acid derivatives (primarily echinocoside), 
flavonoids, essential oils, polyacetylenes, alkylamides and 
polysaccharides [26].
Animals
  Male Swiss albino mice aged 10 ± 1 weeks with an aver-
age weight of 21 ± 2 g were obtained from the Holding 
Company for Biological Products and Vaccines, Cairo, 
Egypt. The animals were kept under good ventilation, at a 
temperature of 22 ± 3°C, 60% humidity, and suitable illu-
mination conditions (light/dark cycle of 14/10 h) and al-
lowed maintenance nutrients and fresh water ad libitum. 
Irradiation
  A 
137Cesium-γ-irradiator was provided by NCRRT, Egypt 
and was manufactured by Atomic Energy of Canada Ltd. 
The dose rate was 0.6 Gy/min of exposure.
Animal groups
  A total of 120 mice were randomly divided into five 
groups of 24 animals each. In addition, each group was fur-
ther divided according to the time of sacrifice. 
  Group A - Control group: Untreated and non-irradiated 
animals were given 1.0 ml normal saline/mouse/day for 2 
weeks.
  Group B - E. purpurea-treated group: Each mouse was 
given an appropriate dose of E. purpurea suspension/day 
for 2 weeks.
  Group C - Irradiated group: Animals were subjected to 
one shot of whole body γ-rays (3 Gy) and then given 1.0 ml 
of normal saline/mouse/day for 2 weeks.
  Group  D  -  E. purpurea-treated and irradiated group 
(radio-protected group): Each mouse was given E. purpur-
ea dosage/day for 2 weeks, and the animal was subjected to 
whole body γ-rays (3 Gy) at one hour after the last dose.
    Group E - Irradiated and E. purpurea-treated group 
(radio- recovery group): Animals were subjected to whole 
body γ-rays (3 Gy), and each mouse was then given E. pur-
purea dosage/day for 2 weeks.
  After the animals in the experimental group had been giv-
en all of the treatments, at intervals of 1, 2 & 4 weeks, the 
animals were sacrificed by cervical dislocation. Since leu-
kocytes and erythrocytes have a relatively short life span of 
about 4 weeks in mice [54], the selected intervals were be-
lieved to reflect the hematological changes preceding irra-
diation [33].
Analytical methods
  All hematological and biochemical parameters were per-
formed according to standard laboratory methods using 
pure chemical materials from Sigma-Aldrich Co, USA. 
Peripheral blood and bone marrow cell count
  Peripheral blood samples were drawn from mice at ex-
perimental intervals of 1, 2 and 4 weeks. The hemoglobin 
(Hb) level, erythrocyte (RBC) count, total leukocyte 
(WBC) count and differential leukocytes (lymphocytes, 
neutrophils and monocytes) were investigated using an au-
tomated blood counter (Coulter Model T-450; Contronics, 
UK). On the same time intervals, femur bone marrow cells 
were prepared as described by Goldberg et al. [17]. Briefly, 
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Table 1. Effect of E. purpurea administration on hemoglobin (Hb) content and the numbers of erythrocytes (RBCs) and total leukocytes
(WBCs) in γ-irradiated mice
Groups Hb (g/ dl) RBCs (× 10
6/ ml) WBCs (/ ml)
   Control
1 week
2 weeks
4 weeks
 12.2 ± 0.88
 12.3 ± 0.57
 12.6 ± 0.91
8.1 ± 0.57 
8.1 ± 0.68 
8.2 ± 0.49
7,633 ± 289.2
7,641 ± 436.1 
7,732 ± 464.3 
   E. purpurea
1 week
2 weeks
4 weeks
 12.3 ± 0.11
 12.1 ± 0.35
 12.2 ± 0.89
8.3 ± 0.38
8.1 ± 0.54
8.2 ± 0.82
7,654 ± 312.5
7,649 ± 401.4
7,782 ± 376.3
   γ-Irradiated (3Gy)
1 week
2 weeks
4 weeks
      9.2 ± 0.84
a,b
    10.2 ± 0.96
a,b
A,B11.4 ± 0.71
a,b
   5.3 ± 0.37
a,b
   6.4 ± 0.73
a,b
   6.5 ± 0.46
a,b
  3,984 ± 586.4
a,b
  4,402 ± 456.6
a,b
  4,478 ± 521.4
a,b
   E. purp. + Irrad.
1 week
2 weeks
4 weeks
   12.1 ± 0.75
c
   12.2 ± 0.82
c
   12.3 ± 0.87
c 
     7.4 ± 0.53
a,b,c
 7.7 ± 0.32
c
 7.9 ± 0.28
c
    5,495 ± 487.2
a,b,c
    6,154 ± 523.4
a,b,c
    A6,975 ± 346.9
a,b,c
   Irrad. + E. purp.
1 week
2 weeks
4 weeks
        11.2 ± 0.75
a,b,c,d
        11.5 ± 0.82
a,b,c.d
   12.3 ± 0.87
c 
     7.2 ± 0.61
a,b,c
 7.6 ± 0.66
c
 7.7 ± 0.42
c
    5,184 ± 617.8
a,b,c
    6,051 ± 553.3
a,b,c
A,B6,876 ± 469.7
a,b,c
ASignificantly different from value at 1week. 
BSignificantly different from value at 2 weeks. 
aSignificantly different from control group. 
bSignificantly different from E. purpurea group. 
cSignificantly different from irradiated (3Gy) group. 
dSignificantly different from irradiation
+ E. purpurea group. p ＜ 0.05.
were washed with 199-medium (Sigma, USA), suspended 
by a syringe with a needles of various diameters, and wash-
ed again 2-3 times with 199 medium by repeated cen-
trifugation at 150 × g for 10 min between each washing 
step. Smears of the cells were drawn on clean slides, fixed 
with methanol for 10 min and stained with May- 
Granwald-Giemsa (Sigma, USA). At least 1,000 cells were 
scored from each animal to determine the total myelokar-
yocyte count and differential elements (lymphoid & eryth-
roid cells). 
Peripheral blood antioxidant activities
  Lipid peroxidation in plasma was determined as thio-
barbituric acid-reactive substances (TBARs) as described 
by Yoshioka et al. [62]. Superoxide dismutase (SOD) and 
glutathione peroxidase (GSPx) activities [32,38] were de-
termined in fresh blood samples obtained from mice.
DNA fragmentation
  Liver  tissues  (100  mg)  were treated with 100 mM 
Tris-HCl, 5 mM EDTA, 150 mM sodium chloride and 
0.5% sarkosyl, pH 8.0, at 4
oC for 10 min. Samples were in-
cubated with ribonuclease (50 µg/ml) and proteinase K 
(100 µg/ml) for 2 h at 37
oC for 45 min. DNA was obtained 
by phenol:chloroform:isoamyl alcohol (25 : 24 : 1) (Sigma, 
USA) extraction, and precipitated with 0.3 M sodium 
chloride and cold isopropanol (1 : 1) at -20
oC for 12 h. 
DNA was recovered by centrifugation of the sample at 
20,800 × g at 4
oC for 10 min. Thereafter, the precipitate 
was washed with 70% ethanol, dried and resuspended in 
Tris containing EDTA (10 mM Tris, 1 mM EDTA) at pH 
8.0. Samples (100 µg DNA) were analyzed on a 1.5% agar-
ose gel with ethidium bromide (0.5 µg/ml).
Raman measurement
  Resonance Raman-spectroscopy was used as a fast and 
non-invasive optical method for measuring protein struc-
tural characterization in liver cells. FT-Raman with multi-
plex and high-throughput properties is able to obtain 
high-quality structural information at the molecular level. 
In the current study, near-infrared FT-Raman was used to 
detect the structural changes in the mouse liver following γ
-irradiation and liver protection with E. purpurea. 
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Table 2. Effect of E. purpurea administration on the numbers of differential leukocytes  in γ-irradiated mice
Groups Lymphocytes (/ml) Neutrophils (/ml) Monocytes (/ml)
   Control
1 week
2 weeks
4 weeks
5,536 ± 289.6 
5,489 ± 268.9
5,571 ± 301.2
1,547 ± 113.5
1,488 ± 104.7
1,592 ± 119.4
405 ± 40.2
398 ± 36.9
412 ± 42.7
   E. purpurea
1 week
2 weeks
4 weeks
5,677 ± 323.5
5,553 ± 271.3
5,668 ± 312.7
1,604 ± 123.1
1,523 ± 111.6
1,606 ± 120.3
409 ± 44.9
401 ± 38.8
388 ± 47.6
   Irradiated (3Gy)
1 week
2 weeks
4 weeks
   2,713 ± 432.4
a,b
   2,909 ± 367.8
a,b
   3,068 ± 287.3
a,b
 1,089 ± 86.5
a,b
 1,052 ± 67.3
a,b
 1,043 ± 72.4
a,b
   187 ± 32.5
a,b
   224 ± 36.6
a,b
  A259 ± 42.4
a,b
   E. purp. + Irrad.
1 week
2 weeks
4 weeks
     4,467 ± 821.4
a,b,c
     4,404 ± 768.3
a,b,c
 5,344 ± 687.2
c
     1,321 ± 124.4
a,b,c
     1,264 ± 112.2
a,b,c
     1,398 ± 103.4
a,b,c
     349 ± 28.6
a,b,c
     351 ± 25.6
a,b,c
  379 ± 21.5
c
   Irrad. + E. purp.
1 week
2 weeks
4 weeks
     4,388 ± 876.5
a,b,c
     4,391 ± 919.3
a,b,c
 4,958 ± 649.7
c
     1,299 ± 155.5
a,b,c
     1,282 ± 116.4
a,b,c
     1,385 ± 123.1
a,b,c
     341 ± 31.1
a,b,c
     348 ± 29.8
a,b,c
 370 ± 23.3
c
ASignificantly different from value at 1week. 
BSignificantly different from value at 2 weeks. 
aSignificantly different from control group. 
bSignificantly different from E. purpurea group. 
cSignificantly different from irradiated (3Gy) group. 
dSignificantly different from irradiation
+ E. purpurea group. p < 0.05.
were obtained using a Nicolet 670 spectrometer with the 
Nicolet Raman module 940 (Thermo Nicolet, USA) and 
Nd
3+ laser operating at 1,064 nm with a maximum power of 
2 W. The system was equipped with an InGaAs (Indium- 
Gallium Arsenide) detector, XT-KBr beam-splitter with 
180-reflective optics, and a fully motorized sample posi-
tion adjustment feature. A laser output power of 2 W was 
used and was low enough to prevent possible laser-induced 
sample damage and a high signal to noise ratio. Data were 
collected at 8 cm
-1 resolution with 256 scans. Spectra were 
obtained in the Raman shift range between 400 and 3,700 
cm
-1. The system was operated using the OMNIC 5.3 soft-
ware and the experiments were replicated three times. The 
intensity ratio of Raman bands 855-832 cm
-1 (I855/832) was 
used to evaluate the microenvironment of tyrosine. Each 
numerical calculation of the Raman intensity ratio was 
based on the average of triplicate measurements.
Statistical analysis
  The data were presented as mean ± SD of 8 mice in each 
group. Comparison between groups was carried out by 
two-way ANOVA “F” test according to Mclauchlan and 
Gowenlok [29], p-values were considered to be significant 
at 5% and determined by Duncan's multiple-range test 
[28].
Results
  There were no significant differences between control 
groups and E. purpurea-treated groups in peripheral blood, 
bone marrow cell count, and peripheral blood antioxidant 
activities at any of the three time intervals. The time inter-
vals of sacrificing also had no effect on the above-men-
tioned parameters within the five study groups (Tables 
1-4). 
  As shown in Table 1, the Hb levels and RBC and WBC 
counts in the γ-irradiated groups showed significant de-
creases in comparison with the control and E. purpur-
ea-treated groups. However, there were significant differ-
ences in Hb level at week 4 as compared with weeks 1 and 
2.       
  In the E. purpurea-treated group followed by irradiation 
(radio-protected group) and irradiated group followed by 
E. purpurea-treatment (radio-recovery group), Hb levels 
during the three time intervals increased significantly in 
comparison to the control group, but the difference in Hb Phytotherapeutic effects of Echinacea purpurea in gamma-irradiated mice    345
Table 3. Effect of E. purpurea administration on total myelokaryocyte, lymphoid and erythroid in γ-irradiated mice
Groups
Myelokaryocyte
(× 10
3/femur)
Lymphoid
(× 10
3/femur)
Erythroid
(× 10
9/femur)
   Control
1 week
2 weeks
4 weeks
105 ± 37.3
109 ± 41.4
107 ± 39.2
 75 ± 21.4
 77 ± 24.3 
 74 ± 19.8
1.11 ± 0.003 
1.23 ± 0.005 
1.22 ± 0.005
   E. purpurea
1 week
2 weeks
4 weeks
120 ± 39.5
120 ± 37.6
123 ± 36.1
    82 ± 28.6
(a)
    95 ± 27.8
(a)
    93 ± 25.7
(a)
1.24 ± 0.006
1.25 ± 0.005
1.24 ± 0.004
   Irradiated (3Gy)
1 week
2 weeks
4 weeks
     50 ± l9.7
a,b
      A73 ± 29.4
a,b
  A,B86 ± 31.9
a,b
    37 ± 11.8
a,b
   A51 ± 15.3
a,b
A,B60 ± 18.4
a,b
   0.61 ± 0.008
a,b  
   0.73 ± 0.007
a,b
  A0.76 ± 0.006
a,b
   E. purp. + Irrad.
1 week
2 weeks
4 weeks
       61 ± 17.7
a,b,c
      A82 ± 33.4
a,b
      A93 ± 34.6
b,c
      44 ± 16.7
a,b,c
      61 ± 17.3
a,b,c
    68 ± 22.2
b,c
 1.02 ± 0.002
c
 1.12 ± 0.001
c 
 1.12 ± 0.009
c
   Irrad. + E. purp.
1 week
2 weeks
4 weeks
       59 ± 18.8
a,b,c
     A79 ± 32.5
a,b
     A88 ± 29.9
a,b
      42 ± 17.3
a,b,c
      58 ± 19.1
a,b,c
    65 ± 24.4
a,b
 0.99 ± 0.004
c
 1.10 ± 0.003
c
 1.11 ± 0.005
c
ASignificantly different from value at 1week. 
BSignificantly different from value at 2 weeks. 
aSignificantly different from control group. 
bSignificantly different from E. purpurea group. 
cSignificantly different from irradiated (3Gy) group.
 dSignificantly different from irradiation+
E. purpurea group. p ＜ 0.05.
level in the radio-recovery group, E. purpurea treated 
group and that of the control and radio-protected groups 
became insignificant at week 4. 
  The RBC count in both the radio-protected and radio-re-
covery groups increased significantly in comparison with 
the irradiated group at each of the three time intervals. The 
RBC count tended to increase towards the counts in both 
the control group and E. purpurea-treated group at weeks 
2 and 4, in both the radio-protected and radio-recovery 
groups. In addition, the total WBC count increased sig-
nificantly in both the radio-protected and radio-recovery 
groups in comparison with the irradiated group at each of 
the three time intervals. There were significant differences 
between the total WBC count at the 4th week as compared 
with its level at the 1st week in the radio-protected group 
while the differences in total WBC count were significant 
in the radio-recovery groups at week 4 in comparison with 
its level during both the 1st and 2nd weeks (Table 1).
  As shown in Table 2, the γ-irradiated groups showed sig-
nificant decreases in the numbers of lymphocytes, neu-
trophils and monocytes as compared with the control group 
and E. purpurea-treated groups. In both the radio-pro-
tected and radio-recovery groups, the differential leuko-
cyte counts tended to increase towards the normal levels at 
all three time intervals.        
  As shown in Table 3, the γ-irradiated groups showed 
marked and significant decreases in the numbers of myelo-
karyocyte, lymphoid and erythroid cells as compared with 
the control and E. purpurea-treated groups. The time inter-
vals had effects on the numbers of myelokaryocyte and 
lymphoid cells at weeks 1 and 2 and in the three types of 
cells at all three time intervals. In both the radio-protected 
and radio-recovery groups, the counts of the three types of 
cells increased significantly compared to the irradiated 
group until the difference in monotype cells between the 
radio-protected and radio-recovery groups and the control 
and E. purpurea-treated groups became insignificant at the 
three time intervals (Table 3).
  As shown in Table 4, the γ-irradiated groups showed 
marked and significant augmentation in TBARs levels at 
the three time intervals as compared with its level in both 
the control and E. purpurea-treated groups. There was a 
significant difference between the TBARs values at weeks 
1 and 4 in the γ-irradiated groups. In contrast, there were 346    Amira M. K. Abouelella et al.
Table 4. Effect of E. purpurea administration on lipid peroxidation (TBARs), superoxide dismutase (SOD) and glutathione peroxidase
(GSPx) in γ-irradiated mice
Groups TBARs (n mol/ dl) SOD (µ mol/ ml) GSPx (µ mol/ ml)
   Control
1 week
2 weeks
4 weeks
4.5 ± 0.39 
4.4 ± 0.37 
4.4 ± 0.41
4.2 ± 0.06
4.2 ± 0.05
4.3 ± 0.04
  0.39 ± 0.018
0.39 ± 0.04
  0.38 ± 0.014
   E. purpurea
1 week
2 weeks
4 weeks
4.4 ± 0.33
4.4 ± 0.29
4.3 ± 0.27
4.5 ± 0.12
4.4 ± 0.15
4.3 ± 0.09
  0.36 ± 0.024
  0.37 ± 0.021
  0.35 ± 0.019
   Irradiated (3Gy)
1 week
2 weeks
4 weeks
   8.3 ± 0.78
a,b
   7.8 ± 0.68
a,b
  A7.2 ± 0.66
a,b 
   2.6 ± 0.24
a,b
   2.8 ± 0.21
a,b
   A3.1 ± 0.17
a,b
     0.23 ± 0.031
a,b
     0.25 ± 0.027
a,b
     A0.28 ± 0.018
a,b
   E. purp. + Irrad.
1 week
2 weeks
4 weeks
     5.3 ± 0.33
a,b.c
     5.1 ± 0.31
a,b.c
 4.6 ± 0.22
c
 3.9 ± 0.18
c
 4.1 ± 0.22
c
 4.1 ± 0.16
c
       0.34 ± 0.017
a,b,c
0.35 ± 0.0
c
   0.35 ± 0.013
c
   Irrad. + E. purp.
1 week
2 weeks
4 weeks
       A6.4 ± 0.53
a,b.c.d
       6.1 ± 0.21
a,b.c.d
       5.8 ± 0.23
a,b.c.d
     3.4 ± 0.12
a,b.c
     3.6 ± 0.14
a,b,c
A4.0 ± 0.13
c 
     0.33 ± 0.11
a,b,c
    0.36 ± 0.017
c
    0.36 ± 0.015
c
ASignificantly different from value at 1week. 
BSignificantly different from value at 2 weeks. 
aSignificantly different from control group. 
bSignificantly differ-
ent from E. purpurea group. 
cSignificantly different from irradiated (3Gy) group. 
dSignificantly different from irradiation + E. purpurea group. p ＜ 0.05.
Fig. 1. Effect of E. purpurea administration on DNA fragmenta-
tion in mouse liver cells. Lane 1 : control group, Lane 2 : E. pur-
purea-treated group, Lane 3 : radio-protected group, Lane 4 : γ
-irradiated group, Lane 5 : radio-recovered group. The absorb-
ance of a representative band of DNA fragmentation was meas-
ured in each sample. The image is representative of the 4-week 
time interval of the experiment.
significant decreases in SOD and GSPx activities as com-
pared to the control and E. purpurea-treated groups. There 
were also significant differences in TBARs value at weeks 
1 and 4 in the γ-irradiated groups.  
  The TBARs levels in both the radio-protected and ra-
dio-recovery groups decreased significantly as compared 
with the γ-irradiated groups, but the decrease in the ra-
dio-protected groups was greater than that in the radio-re-
covery groups at the three time intervals. The activities of 
SOD and GSP increased significantly in both the ra-
dio-protected and radio-recovery groups as compared with 
the γ-irradiated groups (Table 4).   
  The administration of E. purpurea before γ-exposure re-
duced apoptosis as measured by DNA fragmentation (Fig. 
1). In our experiments, the DNA fragmentation in the 
mouse liver cells could not be recovered by the admin-
istration of E. purpurea after γ-irradiation.
  Fig. 2 shows the Raman spectra, which ranged from 400 
to 3,700 cm
-1, of mouse livers in the control group (A), E. 
purpurea-treated group (B), 3 Gy gamma-irradiated group 
(C), radio-protected group (D) and radio-recovery group 
(E). The secondary structure information, primarily seen as 
antiparallel β-pleated sheets, was indicated by the vibra-Phytotherapeutic effects of Echinacea purpurea in gamma-irradiated mice    347
Fig. 2. A: Raman spectra in the 400-3,700 cm
򰠏1 region of control mouse liver (A), E. purpurea-treated mice (B), 3 Gy γ-irradiated mice
(C), radio-protected mice (D), and radio-recovered mice (E). The spectra represent the samples at the 4-week time interval of the 
experiment. B: The expanded spectral region for amide I, amide III and tyrosine.
tional stretch of amide I (∼1,670 cm
򰠏1) and amide III (∼
1,241 cm
򰠏1) only in Groups A and B. The secondary struc-
ture of the protein in the mouse liver was not stable in C and 
amide I was shifted to ∼1,590 cm
򰠏1 while amide III was 
stable. In Group D, the secondary structure of the protein in 
liver cells was stable enough to resist changes in the 
spectra. The comparison of the Raman spectra of the ra-
dio-recovery group (E) in Fig. 2 and the control group (A) 
showed that the vibrational stretch of amide I was shifted to 
∼1,620 cm
򰠏1. The vibrational stretch of amide III in Group 
C could not be detected by Raman spectra, while the amide 
III in Group E was shifted to 1,180 cm
򰠏1.             
  The tyrosine residues were detected at the doublet Raman 
shift of 855 and 832 cm
򰠏1. The ratio of both doublets in-
dicated the hydrogen bonding environment in the liver. 
The intensity ratios (I855/832) for A, B, C, D, and E Group 
were 0.48, 0.47, 1.25, 0.62 and 1.17, respectively. In other 
words, the tyrosine residues in Group C were greatly af-
fected by radiation. The tyrosine residues in Group D were 
more susceptible to E. purpurea treatment before radiation 
than the E. purpurea treatment after radiation (Group E).
Discussion
  E. purpurea has generally been considered to be safe and 
without significant toxicity, significant herb-drug inter-
actions, contraindications, or adverse side effects [8,23, 
28]. 
  The hematopoietic system is known to be one of the most 
radiosensitive systems, and its damage may play lead to the 
development of hematopoietic syndrome and result in 
death. Survival after irradiation actually results from the 
recovery of several target systems, such as the bone mar-
row, gastrointestinal tract, skin and hemostatic systems 
[59]. Death from the so-called hematopoietic syndrome re-
sults from infection due to the impairment of the immune 
system [11]. Various mechanisms, such as the prevention 
of damage through the inhibition of free radical generation 
or its intensified scavenging, enhancement of DNA and 
membrane repair, replacement of dead hematopoietic and 
other cells and the stimulation of immune-cells activities, 
are considered to be important approaches for radio-pro-
tection and radio-recovery [36].
  In the present study, the reduction in both Hb level and 
RBC count at each of the three time intervals in the irradi-
ated groups were attributed to the impairment of cell divi-
sion, obliteration of blood-forming organs, alimentary 
tract injury [14], depletion of factors needed for erythro-
blast differentiation and reticulocyte release from the bone 
marrow [18] and the loss of cells from the circulation by 
hemorrhage or leakage through capillary walls and/or the 
direct destruction of mature circulating cells [53]. Reco-
very of both Hb level and RBC count was evident in both 
the protected and recovered groups, but the recovery of the 
Hb parameter was more distinct in the radio-protection 
group than in the radio-recovery group. In contrast, the 
RBC counts in the radio-protection and radio-recovery 
groups were the same as those of the control, E. purpurea- 348    Amira M. K. Abouelella et al.
treated and irradiated groups.
  The present work describes the marked decrease in WBC 
count in mice subjected to irradiation at three time 
intervals. Irradiation-induced leucopoenia has likewise 
been reported in γ-ray irradiated mice [33]. It seems appa-
rent that the leucopoenia observed in these mice was a di-
rect consequence of the lymphopenia and neutropenia that 
occurred following irradiation. An obvious degree of ei-
ther radio-protection or radio-recovery was obtained using 
E. purpurea. These results agree with the findings of 
Barrett [3] and Widel [59], who reported that Echinacea 
preparations influenced the leukocyte count, stimulated 
the phagocytic activity and/or increased the release of 
cytokines. It has been suggested that Echinacea is able to 
stimulate innate immune responses, including those regu-
lated by macrophages and natural killer cells (white blood 
cells). In addition, macrophages respond to purified poly-
saccharide and alkylamide preparations incorporated into 
Echinacea. Treatment with ionizing radiation resulted in 
cytokine-mediated cellular damage [30]. For patients un-
dergoing radiation and chemotherapy treatments, studies 
have proven that E. purpurea, while boosting the immune 
system, also produced additional white blood cells and 
stimulated bone marrow production, which was dimin-
ished by chemotherapy [43]. However, the mechanisms of 
stimulation for cells responsible for adaptive immunity 
have not been fully elucidated for the other molecules pres-
ent in E. purpurea preparations [22].
  Since the peripheral blood pattern observed during the en-
tire post-irradiation period was primarily a reflection of 
processes occurring in hematopoietic organs [59], the sig-
nificant protective effects of E. purpurea against lymphoid 
cell death in bone marrow can lead to their accelerated re-
covery in peripheral blood. In fact, the tendency to return to 
the normal value of reduced blood leukocyte count 
throughout the three time intervals was more rapid in the E. 
purpurea-treated groups both before and after irradiation 
than in the irradiated mice.
  In this study, lymphocytes, neutrophils and monocytes 
were significantly decreased throughout the three time 
intervals. Mature lymphocytes are considered to be the 
most sensitive type of blood cell [60], and the earliest blood 
change following whole body irradiation is lymphopenia 
[45]. Neutrophils have a half-life of only about 10-12 h 
once they leave the marrow, a site that serves as a reservoir 
for mature neutrophils [34]. These data agree with the find-
ings of Kafafy et al. [25]. The data showed that E. purpurea 
administration has significant radio-protective and ra-
dio-recovery effects on the levels of lymphocytes, neu-
trophils and monocytes.
  It has been reported that E. purpurea has an IFN-like ef-
fect, activating macrophages and inducing the production 
of interleukin -1 (IL-1) and IFN [48]. In addition, Mishima 
et al. [33] reported that the administration of E. purpurea 
had a suppressive effect on radiation-induced leucopoenia, 
especially on lymphocytes and monocytes, and resulted in 
a faster recovery of the blood cell count in mice and rabbits 
[24]. In addition, peripheral blood antioxidant activity was 
increased by E. purpurea, which suggested a relationship 
between the antioxidant effect and the suppressive effects 
on radiation-induced leucopoenia. In contrast, Schwarz et 
al. [48] reported that the oral administration of E. purpurea 
for 2 weeks had only minor effects on 2 out of 12 lympho-
cyte subpopulations determined by flow-cytometry in a 
double-blind, placebo-controlled cross-over study. 
  In the present study, irradiation caused remarkable in-
creases in the TBARs content and incredible decreases in 
the activities of SOD and GSPx. Zahran et al. [63] and 
Tawfik et al. [54] recently confirmed these finding. After 
the administration of E. purpurea, the TBARs level and an-
tioxidant activities were attenuated in comparison to their 
values in irradiated mice at each of the three time intervals. 
The mechanisms of antioxidant activity in the extracts de-
rived from Echinacea included free radical scavenging and 
transition metal chelating properties [23]. 
  Several experimental models have described the in vivo 
and in vitro protection from liver injury induced by free 
radicals [1,40].  They reported that prostaglandin (PGE1) 
was able to reduce DNA fragmentation in rat hepatocytes 
and that it protected against galactosamine (D-GalN)- in-
duced apoptosis. It is interesting to note that the admin-
istration of Echinacea also reduced the effects of gamma 
irradiation on DNA fragmentation. In contrast, the admin-
istration of Echinacea after gamma exposure was not ef-
fective at reducing the apoptotic mechanisms induced by 
gamma irradiation. The protection provided by Echinacea 
against apoptosis induced by gamma irradiation may be as-
sociated with its ability to block the induction of internal 
factors, such as inducible nitric oxide synthase (iNOS) and 
nitric oxide (NO) production. In fact, Echinacea was able 
to slightly enhance DNA fragmentation in control cells. 
Nevertheless, more studies are needed in order to confirm 
these findings. 
  The secondary structure of liver proteins is easily moni-
tored by observing the frequencies of amide I and amide III 
originating from a peptide backbone [50]. The sharpening 
of amide I peaks in A, B and D may indicate the uniformity 
of hydrogen bonds whereas the flattening of amide I in the 
gamma-irradiated mice (Group C) and its shifting to 1,590 
cm
-1 may indicate the loss of uniformity in hydrogen 
bonds. 
  In the liver, tyrosine is a key component of many en-
zymes, which may be inhibited through the oxidative mod-
ification of their tyrosine residues. Therefore, it is very im-
portant to probe the microenvironment of tyrosine. Shih et 
al. [51] reported that the tyrosine doublet at 850
-1 and 830 
cm
-1 was sensitive to the nature of the hydrogen bond of the 
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face of a protein in aqueous solution, the phenolic OH will 
simultaneously act as an acceptor and donor of moderate to 
weak H-bonds, and the doublet intensity ratio (I850/830) will 
be about 1 : 0.8 (I = 1 : 25). If the phenolic oxygen is the ac-
ceptor atom in a strong H-bond, the intensity ratio will be 
about 1 : 0.4 (I = 2 : 5). If the phenolic hydroxyl is the pro-
ton donor in a strong H-bond, the intensity ratio will be ap-
proximately 1 : 2 (I = 0.5). Accordingly, the current result 
that the intensity ratio in the gamma-irradiated mice 
(Group C) was about 1 : 0.8 might indicate that the phe-
nolic hydroxyl of tyrosine was on the surface of liver pro-
teins with a moderate to weak H-bond. On the other hand, 
the doublet intensity ratio in the radio-protected mice 
(Group D) was sensitive to the level of E. purpurea admin-
istration, as shown in Fig. 2b. However, the mechanisms 
by which these antioxidative effects protect major liver 
constituents, including thiol compounds, tyrosine, trypto-
phan, and water content, from oxidative insults remains to 
be elucidated.
  Weiss and Landauer [58] documented a protective effect 
of polyphenols from Echinacea against free radical dam-
age and a class of specific antioxidants known as caffeoyl 
derivatives in appreciable amounts. Furthermore, Sasagawa 
et al. [44] reported that the alkylamides present in 
Echinacea species inhibited IL action and hypothesized 
that the constituents present in its dry extracts exert direct 
immunomodulatory effects on the immune system [44]. In 
addition, single X-ray irradiation causes considerable dis-
turbances to the liver. The administration of Echinacea 
tinctures was assumed to induce their beneficial effects, 
primarily by stimulating certain components of the non- 
specific immune system. Previous studies have proven that 
the most important pharmacological effects were the stim-
ulation of the phagocytic activity of polymorphonuclear 
leucocytes and other phagocytes [3], as well as the activa-
tion of phagocytes to produce the pro-inflammatory cyto-
kines TNF-α, IL-1, IL-6 and other mediators [4]. 
  E. purpurea was able to regulate the process of apoptosis 
in-vivo. The splenic-lymphocytes from mice orally treated 
with Echinacea for 14 days at a dose of level 30 mg kg
-1 per 
day were shown to be significantly more resistant to apop-
tosis than those from mice treated only with the vehicle 
[13]. Moreover, Gan et al. [16] demonstrated that 
Echinacea extracts are potent activators of natural killer 
(NK) cytotoxicity, augmented the frequency of NK target 
conjugates and activated the programming for NK cell 
lysis. The Echinacea extracts also enhanced the anti-
body-forming cell response and humeral immune re-
sponses as well as the innate immune responses in female 
mice [15]. It also enhanced the nonspecific immune or cel-
lular immune systems (or both) in the AKR/J-mice [20]. It 
also sensitized the immune cells and led to lifespan pro-
longation in mice [12].
  Raso et al. [41] evaluated the anti-inflammatory activity 
of E. purpurea in mice treated at doses of 30 and 100 mg 
kg
-1 twice daily. Only the higher-dose treatment sig-
nificantly inhibited the formation of edema in a time-de-
pendent manner. Western blot analysis showed that in vivo 
treatment with this extract could modulate lipo-poly-
saccharide and INF-γ-induced cyclooxygenase-2 (COX- 
2) and iNOS expression in peritoneal macrophages. They 
suggested that the anti-inflammatory effect of that partic-
ular extract could be in part related to its modulation of 
COX-2 expression.
  The mechanisms of the stimulatory effect observed in the 
present study remain to be clarified. The authors suggest 
that the factors that might be involved are changes in the in-
testinal absorption of immune stimulating-compounds 
present in the Echinacea preparation caused by the 
irradiation. Brinker [10] reported that the experimental 
success of the oral administration of the immunostimulant 
E. purpurea was probably due to the receptor binding of its 
polymeric markers on mucosal- or gut-associated lym-
phoid tissues. 
  In conclusion, the immune stimulatory ability of E. pur-
purea extracts may have a therapeutic potential to regulate 
the protection and recovery of immune responses as well as 
the activation measures in irradiated mice.
  Therefore, further studies are needed to clarify the mecha-
nism(s) that are responsible for the beneficial effect of 
Echinacea preparations observed in this study, and future 
research must also be conducted on the use of E. purpurea 
as an immunonutrient and useful adjunct to conventional 
cancer therapies because of its immune-stimulating pro-
perties.
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